Stock Markets February 11, 2026

S&P Lowers Empresas CMPC Rating to BBB- Citing Weaker Earnings and Elevated Leverage

Agency points to falling pulp prices, tougher regional competition and a sizable capex decision on the horizon

By Caleb Monroe
S&P Lowers Empresas CMPC Rating to BBB- Citing Weaker Earnings and Elevated Leverage

S&P Global Ratings has cut Empresas CMPC S.A.'s credit rating one notch to 'BBB-' from 'BBB', assigning a stable outlook. The decision reflects a decline in S&P-adjusted EBITDA to just under $1.1 billion in 2025 from nearly $1.5 billion in 2024, a leverage peak of 4.5x at year-end 2025, and pressures from softer pulp prices and intensified competition in tissue and personal care markets. S&P forecasts gradual earnings recovery and lower leverage through 2027, incorporates planned asset sales of about $450 million in 2026, and expects possible approval of CMPC's large Natureza pulp mill project in early 2026.

Key Points

  • S&P downgraded Empresas CMPC S.A. to 'BBB-' from 'BBB', assigning a stable outlook due to weaker-than-expected results and elevated leverage.
  • S&P-adjusted EBITDA fell to slightly below $1.1 billion in 2025 from almost $1.5 billion in 2024, with leverage peaking at 4.5x by year-end 2025; agency forecasts EBITDA recovery to $1.2-1.3 billion in 2026 and $1.4-1.5 billion in 2027.
  • Average BEKP prices in China dropped 17% in 2025; S&P expects prices of about $580/ton in 2026 and $650/ton in 2027, and incorporates roughly $450 million of asset sales in 2026 into its base-case.

S&P Global Ratings has downgraded Empresas CMPC S.A.'s long-term rating to 'BBB-' from 'BBB' while keeping the outlook stable. The rating action stems from weaker-than-expected operating results and the company's difficulty in lowering leverage after a material earnings contraction in 2025.

Earnings and leverage trajectory

S&P's adjustments show CMPC's EBITDA fell to slightly below $1.1 billion in 2025, down from almost $1.5 billion in 2024. That deterioration contributed to a leverage ratio that peaked at 4.5x by the end of 2025. The rating agency attributes the decline in underlying earnings power primarily to continued weakness in pulp prices and heightened competition in regional tissue and personal care segments, notably in Brazil and Mexico.

Market dynamics pressuring margins

The average bleached eucalyptus kraft pulp (BEKP) price in China slid by 17% in 2025, according to S&P, a drop the agency connects to global trade tensions, an overcapacity of paper in China, and the country's rise in integrated pulp capacity. Those forces, S&P says, have produced more pronounced margin compression than initially expected for CMPC.

S&P projects some recovery in BEKP prices over the next two years, estimating an average of about $580 per ton in 2026 and $650 per ton in 2027 - up from $540 per ton in 2025. The agency's baseline for CMPC incorporates those price improvements as part of an easing in supply-demand imbalances.

Management actions and balance-sheet plans

CMPC's management has publicly outlined an asset monetization program that would include sales of land, forestry holdings and power generation assets. In its base-case, S&P factors in roughly $450 million of asset disposals occurring in 2026.

Using those assumptions, S&P forecasts S&P Global Ratings-adjusted EBITDA of $1.2 billion to $1.3 billion in 2026 and $1.4 billion to $1.5 billion in 2027, with leverage falling to close to 3.0x in 2026 and to about 2.5x in 2027. The agency's stable outlook reflects a view that, given somewhat improved market conditions and management's debt-reduction measures, leverage will trend down and remain compatible with the current rating over the next two years.

Capital expenditure decision looms

S&P also notes that CMPC is likely to approve the Natureza Project - a new BHKP pulp mill with capacity of 2.5 million tons per year and an estimated investment of $4.6 billion - in the first half of 2026. While the project is described by S&P as strategically important to CMPC's long-term competitiveness, the agency warns it would require further adjustments to the company's capital structure to avoid materially deviating from its financial policy.

Implications and outlook

In sum, the downgrade reflects a combination of near-term earnings pressure from cyclical and structural market forces, ongoing competition in key regional end-markets, and the balance-sheet impact of weaker 2025 results. S&P's forward-looking assumptions include partial price recovery for BEKP, proceeds from planned asset sales, and management actions aimed at reducing leverage, which together support the agency's view that CMPC's credit profile can be consistent with the downgraded rating over the coming two years.


Summary

S&P cut CMPC to 'BBB-' from 'BBB' with a stable outlook after adjusted EBITDA fell to just under $1.1 billion in 2025 from nearly $1.5 billion in 2024 and leverage peaked at 4.5x. The agency points to weak pulp prices - with BEKP down 17% in China in 2025 - and tougher regional competition as primary drivers. S&P forecasts gradual recovery in prices and earnings through 2027, incorporates about $450 million of asset sales in 2026, and notes the likely approval of the $4.6 billion Natureza pulp mill in H1 2026, which would necessitate additional capital-structure adjustments.

Risks

  • Sustained weakness in pulp prices and continued regional competition - particularly in tissue and personal care markets in Brazil and Mexico - could further compress margins and delay earnings recovery.
  • Approval and execution of the Natureza Project - a proposed 2.5 million tpy BHKP mill with an estimated $4.6 billion investment - would require additional capital-structure adjustments to avoid significant deviation from CMPC's financial policy.

More from Stock Markets

Switzerland Pulling Ahead in Early Economic Gains from AI Feb 22, 2026 Nvidia Results and Software Earnings to Test AI-Driven Market Sentiment Feb 22, 2026 Analysts Shift AI Bets: Nvidia, Amazon, Dell, Analog Devices, Shopify See Upgrades and Bullish Casework Feb 22, 2026 Investors Trim Positions in EssilorLuxottica Amid Smart-Glasses Threat Feb 22, 2026 European Equities Split Between Defense, Financials Rally and Consumer, Healthcare Slump Feb 22, 2026